Innealta Capital’s Dorman Products DORM Stock Holding History

Innealta Capital’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2	Closed	-$183	–	588
2024 Q2	$183	Buy	+2	New	+$183	﹤0.01%	1621

Other funds holding DORM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Innealta Capital's DORM Position: Q3 2024 in Review

Innealta Capital sold out of Dorman Products (DORM) in Q3 2024, closing a stake of 2 shares — an estimated $183 sold.

Innealta Capital first reported a position in DORM in Q2 2024 and held it in 1 quarter. The position peaked at $183 in Q2 2024. 303 funds tracked by Wall St. Rank hold DORM as of Q3 2024.

Innealta Capital reported no remaining Dorman Products position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 2 Dorman Products shares in Q3 2024, an estimated $183.
Innealta Capital first reported a position in Dorman Products in Q2 2024 and held it in 1 quarter.
Innealta Capital's Dorman Products position peaked at $183 in Q2 2024.
303 funds tracked by Wall St. Rank held Dorman Products as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.